TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Entire Construction Budget In 1983 Goes to Two Grants; Help May Be On The Way February 25, 1983
TCL Archive In Brief: Weicker Heads New Group For More Spending On Medical Research; Committee Oks Sullivan March 3, 1989
TCL Archive Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate February 14, 2014
TCL Archive In Brief: Baltimore Resigns as Rockefeller President; Perry Named Medical Director At Ellis Fischel December 13, 1991
